Osmind

Osmind is a San Francisco-based neurotechnology company that develops a specialized electronic health record and practice management platform tailored exclusively for psychiatric providers delivering innovative mental health treatments. Their software is purpose-built to support clinics offering ketamine infusions, transcranial magnetic stimulation, and esketamine therapies such as Spravato, addressing the unique operational demands of these emerging treatment modalities. The platform integrates patient intake, structured outcome tracking, and billing workflows into a unified system, reducing administrative burden and enabling clinicians to focus on delivering care. By designing specifically for this underserved segment of psychiatry, Osmind fills a critical gap left by general-purpose EHR platforms that were not built with these complex, protocol-driven treatments in mind.

Osmind has established itself as a leading software infrastructure provider within the rapidly growing market for interventional psychiatry, securing a Series B funding round of 40 million dollars to support its expansion. The company has built a substantial network of psychiatric clinics across the United States, positioning itself as the de facto platform for providers at the forefront of mental health innovation. Their outcome-tracking capabilities also contribute to a growing real-world dataset on treatment-resistant depression and related conditions, offering potential value beyond clinical operations. This combination of operational software and data collection has helped Osmind attract both provider adoption and investor confidence in a competitive healthcare technology landscape.

Osmind represents a meaningful force in the broader neurotechnology industry by building the foundational infrastructure necessary to scale next-generation psychiatric treatments into mainstream clinical practice. As ketamine and TMS therapies gain regulatory acceptance and clinical validation, the operational complexity of running these practices demands software solutions sophisticated enough to match the science. Osmind directly accelerates adoption of these treatments by lowering the administrative and logistical barriers that might otherwise prevent smaller clinics from offering them. In doing so, the company plays a connective role between neuroscience innovation and real-world patient access, making it a strategically important player in the future of mental health care delivery.